Abstract
Diagnostic strategies for congenital toxoplasmosis have changed profoundly in recent years. Immunological diagnostic methods, long considered disappointing, can now be used at a very early stage. Over a 3-year period, 1,050 infants at risk of congenital toxoplasmosis (born to 1,048 mothers infected during pregnancy) were monitored for a minimum of 12 months and a maximum of 7 years. More than 6,000 serum specimens were analyzed by comparative mother-infant immunological profiles (CIPs) based on an enzyme-linked immunofiltration assay (ELIFA) and an immunocapture method for the detection of specific immunoglobulin M (IgM) and IgA. IgG antibodies were also titrated. One hundred three cases of congenital toxoplasmosis were demonstrated. The CIP-ELIFA method had a better diagnostic yield (sensitivity, 90%) than specific IgM and/or IgA detection by immunocapture assay (sensitivity, 77%). By using a combination of these tests, congenital infection was diagnosed in the first month and the first 3 months of life in 90 and 94% of infants with toxoplasmosis, respectively, with a specificity of 99.8% and a positive predictive value of 99% at 8 months of age. This dual diagnostic approach (ELIFA and IgM-IgA immunocapture) is highly efficient and has important implications for therapy. Indeed, early postnatal diagnosis based on objective evidence enables therapy with pyrimethamine-sulfadoxine to be started immediately for 24 months, while spiramycin (which used to be given preventively for 9 to 12 months to all infants at risk) can be stopped after the first 3 months of life.
Full Text
The Full Text of this article is available as a PDF (249.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bessières M. H., Roques C., Berrebi A., Barre V., Cazaux M., Séguéla J. P. IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol. 1992 Jul;45(7):605–608. doi: 10.1136/jcp.45.7.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Couvreur J., Desmonts G., Aron-Rosa D. Le pronostic oculaire de la toxoplasmose congénitale: rôle du traitement. Communication préliminaire. Ann Pediatr (Paris) 1984 Nov;31(10):855–858. [PubMed] [Google Scholar]
- Couvreur J., Desmonts G., Tournier G., Szusterkac M. Etude d'une série homogène de 210 cas de toxoplasmose congénitale chez des nourrissons âgés de 0 à 11 mois et dépistés de facon prospective. Ann Pediatr (Paris) 1984 Nov;31(10):815–819. [PubMed] [Google Scholar]
- Couvreur J., Thulliez P., Daffos F., Aufrant C., Bompard Y., Gesquière A., Desmonts G. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine. Fetal Diagn Ther. 1993 Jan-Feb;8(1):45–50. doi: 10.1159/000263746. [DOI] [PubMed] [Google Scholar]
- Decoster A., Slizewicz B., Simon J., Bazin C., Darcy F., Vittu G., Boulanger C., Champeau Y., Demory J. L., Duhamel M. Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies. J Clin Microbiol. 1991 Oct;29(10):2291–2295. doi: 10.1128/jcm.29.10.2291-2295.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Desmonts G., Naot Y., Remington J. S. Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol. 1981 Nov;14(5):486–491. doi: 10.1128/jcm.14.5.486-491.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Desmonts G., Remington J. S. Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol. 1980 Jun;11(6):562–568. doi: 10.1128/jcm.11.6.562-568.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foudrinier F., Marx-Chemla C., Aubert D., Bonhomme A., Pinon J. M. Value of specific immunoglobulin A detection by two immunocapture assays in the diagnosis of toxoplasmosis. Eur J Clin Microbiol Infect Dis. 1995 Jul;14(7):585–590. doi: 10.1007/BF01690729. [DOI] [PubMed] [Google Scholar]
- Garin J. P., Mojon M., Piens M. A., Chevalier-Nuttall I. Surveillance et traitement de la toxoplasmose chez la femme enceinte, le foetus et le nouveau-né. Pediatrie. 1989;44(9):705–712. [PubMed] [Google Scholar]
- Guerina N. G., Hsu H. W., Meissner H. C., Maguire J. H., Lynfield R., Stechenberg B., Abroms I., Pasternack M. S., Hoff R., Eaton R. B. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med. 1994 Jun 30;330(26):1858–1863. doi: 10.1056/NEJM199406303302604. [DOI] [PubMed] [Google Scholar]
- Koppe J. G., Loewer-Sieger D. H., de Roever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet. 1986 Feb 1;1(8475):254–256. doi: 10.1016/s0140-6736(86)90785-3. [DOI] [PubMed] [Google Scholar]
- Le Fichoux Y., Marty P., Chan H. Les IgA sériques spécifiques dans le diagnostic de la toxoplasmose. Ann Pediatr (Paris) 1987 May;34(5):375–379. [PubMed] [Google Scholar]
- Mirlesse V., Jacquemard F., Daffos F. Toxoplasmose au cours de la grossesse. Diagnostic et nouvelles possibilités thérapeutiques. Presse Med. 1993 Feb 20;22(6):258–262. [PubMed] [Google Scholar]
- Pinon J. M., Poirriez J., Leroux B., Dupouy D., Quereux C., Garin J. P. Diagnostic précoce et surveillance de la toxoplasmose congénitale. Méthode des profils immunologiques comparés. Presse Med. 1987 Mar 21;16(10):471–474. [PubMed] [Google Scholar]
- Pinon J. M., Thoannes H., Gruson N. An enzyme-linked immuno-filtration assay used to compare infant and maternal antibody profiles in toxoplasmosis. J Immunol Methods. 1985 Feb 28;77(1):15–23. doi: 10.1016/0022-1759(85)90179-6. [DOI] [PubMed] [Google Scholar]
- Pinon J. M., Thoannes H., Pouletty P. H., Poirriez J., Damiens J., Pelletier P. Detection of IgA specific for toxoplasmosis in serum and cerebrospinal fluid using a non-enzymatic IgA-capture assay. Diagn Immunol. 1986;4(5):223–227. [PubMed] [Google Scholar]
- Pinon J. M., Toubas D., Marx C., Mougeot G., Bonnin A., Bonhomme A., Villaume M., Foudrinier F., Lepan H. Detection of specific immunoglobulin E in patients with toxoplasmosis. J Clin Microbiol. 1990 Aug;28(8):1739–1743. doi: 10.1128/jcm.28.8.1739-1743.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pouletty P., Kadouche J., Garcia-Gonzalez M., Mihaesco E., Desmonts G., Thulliez P., Thoannes H., Pinon J. M. An anti-human mu chain monoclonal antibody: use for detection of IgM antibodies to Toxoplasma gondii by reverse immunosorbent assay. J Immunol Methods. 1985 Feb 11;76(2):289–298. doi: 10.1016/0022-1759(85)90306-0. [DOI] [PubMed] [Google Scholar]
- Remington J. S., Araujo F. G., Desmonts G. Recognition of different Toxoplasma antigens by IgM and IgG antibodies in mothers and their congenitally infected newborns. J Infect Dis. 1985 Nov;152(5):1020–1024. doi: 10.1093/infdis/152.5.1020. [DOI] [PubMed] [Google Scholar]
- Schoondermark-Van de Ven E., Melchers W., Camps W., Eskes T., Meuwissen J., Galama J. Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys. Antimicrob Agents Chemother. 1994 Sep;38(9):1930–1936. doi: 10.1128/aac.38.9.1930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stepick-Biek P., Thulliez P., Araujo F. G., Remington J. S. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis. 1990 Jul;162(1):270–273. doi: 10.1093/infdis/162.1.270. [DOI] [PubMed] [Google Scholar]
- Stray-Pedersen B. Treatment of toxoplasmosis in the pregnant mother and newborn child. Scand J Infect Dis Suppl. 1992;84:23–31. [PubMed] [Google Scholar]
- Wilson C. B., Remington J. S., Stagno S., Reynolds D. W. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980 Nov;66(5):767–774. [PubMed] [Google Scholar]
- Wong S. Y., Hajdu M. P., Ramirez R., Thulliez P., McLeod R., Remington J. S. Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. J Clin Microbiol. 1993 Nov;31(11):2952–2959. doi: 10.1128/jcm.31.11.2952-2959.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]